Evidence Based Optimal Dosing of Intravenous Artesunate in Children with Severe Falciparum Malaria

The majority of deaths from malaria are in young African children. Parenteral artesunate (ARS) is the first-line treatment for severe falciparum malaria. Since 2015, the World Health Organization has recommended individual doses of 3 mg/kg for children weighing

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology and therapeutics 2023-12, Vol.114 (6), p.1304-1312
Hauptverfasser:	Haghiri, Ali, Price, David J, Fitzpatrick, Phoebe, Dini, Saber, Rajasekhar, Megha, Fanello, Caterina, Tarning, Joel, Watson, James, White, Nicholas J, Simpson, Julie A
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Adolescent Antimalarials - adverse effects Artesunate - therapeutic use Bayes Theorem Child Humans Malaria - drug therapy Malaria, Falciparum - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!